Mechanisms of disease: protease functions in intestinal mucosal pathobiology

被引:83
作者
Antalis, Toni M.
Shea-Donohue, Terez
Vogel, Stefanie N.
Sears, Cynthia
Fasano, Alessio
机构
[1] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA
[3] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
来源
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY | 2007年 / 4卷 / 07期
关键词
enteric pathogen; inflammation; intestinal permeability protease; protease activated receptor;
D O I
10.1038/ncpgasthep0846
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Of all our organ systems, the gastrointestinal tract contains the highest levels of endogenous and exogenous proteases (also known as proteinases and peptidases); however, our understanding of their functions and interactions within the gastrointestinal tract is restricted largely to nutrient digestion. The gut epithelium is a sensor of the luminal environment, not only controlling digestive, absorptive and secretory functions, but also relaying information to the mucosal immune, vascular and nervous systems. These functions involve a complex array of cell types that elaborate growth factors, cytokines and extracellular matrix (ECM) proteins, the activity and availability of which are regulated by proteases. Proteolytic activity must be tightly regulated in the face of diverse environmental challenges, because unrestrained or excessive proteolysis leads to pathological gastrointestinal conditions. Moreover, enteric microbes and parasites can hijack proteolytic pathway through 'pathogen host mimicry'. Understanding how the protease balance is maintained and regulated in the intestinal epithelial cell microenvironment and how proteases contribute to physiological and pathological outcomes will undoubtedly contribute to the identification of new potential therapeutic targets for gastrointestinal diseases.
引用
收藏
页码:393 / 402
页数:10
相关论文
共 87 条
[1]   Ascaris nematodes from pig and human make three antibacterial peptides:: isolation of cecropin P1 and two ASABF peptides [J].
Andersson, M ;
Boman, A ;
Boman, HG .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (03) :599-606
[2]   Serpin mutagenesis [J].
Antalis, TM ;
Lawrence, DA .
METHODS, 2004, 32 (02) :130-140
[3]   Memory TH2 cells induce alternatively activated macrophages to mediate protection against nematode parasites [J].
Anthony, Robert M. ;
Urban, Joseph F., Jr. ;
Alem, Farhang ;
Hamed, Hossein A. ;
Rozo, Cristina T. ;
Boucher, Jean-Luc ;
Van Rooijen, Nico ;
Gause, William C. .
NATURE MEDICINE, 2006, 12 (08) :955-960
[4]   The basic science of wound healing [J].
Broughton, George, II ;
Janis, Jeffrey E. ;
Attinger, Christopher E. .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2006, 117 (07) :12S-34S
[5]   Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration [J].
Cao, Chunzhang ;
Lawrence, Daniel A. ;
Li, Yang ;
Von Arnim, Christine Af ;
Herz, Joachim ;
Su, Enming J. ;
Makarova, Alexandra ;
Hyman, Bradley T. ;
Strickland, Dudley K. ;
Zhang, Li .
EMBO JOURNAL, 2006, 25 (09) :1860-1870
[6]   PAR2 activation alters colonic paracellular permeability in mice via IFN-γ-dependent and -independent pathways [J].
Cenac, N ;
Chin, AC ;
Garcia-Villar, R ;
Salvador-Cartier, C ;
Ferrier, L ;
Vergnolle, N ;
Buret, AG ;
Fioramonti, J ;
Bueno, L .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 558 (03) :913-925
[7]   Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2 [J].
Cenac, N ;
Coelho, AM ;
Nguyen, C ;
Compton, S ;
Andrade-Gordon, P ;
MacNaughton, WK ;
Wallace, JL ;
Hollenberg, MD ;
Bunnett, NW ;
Garcia-Villar, R ;
Bueno, L ;
Vergnolle, N .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (05) :1903-1915
[8]   Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function [J].
Clemente, MG ;
De Virgiliis, S ;
Kang, JS ;
Macatagney, R ;
Musu, MP ;
Di Pierro, MR ;
Drago, S ;
Congia, M ;
Fasano, A .
GUT, 2003, 52 (02) :218-223
[9]  
Cottrell GS, 2003, BIOCHEM SOC T, V31, P1191
[10]   Trypsin IV, a novel agonist of protease-activated receptors 2 and 4 [J].
Cottrell, GS ;
Amadesi, S ;
Grady, EF ;
Bunnett, NW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (14) :13532-13539